Bal Pharma Limited (BOM:524824)
India
· Delayed Price · Currency is INR 71.86
+2.06 (2.95%)
At close: Mar 10, 2026
Bal Pharma Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Market Capitalization | 1,144 | 1,314 | 1,432 | 1,050 | 1,599 | 797 | Upgrade
|
| Market Cap Growth | -31.02% | -8.20% | 36.34% | -34.31% | 100.65% | 72.70% | Upgrade
|
| Enterprise Value | 2,602 | 2,637 | 2,758 | 2,031 | 2,587 | 1,830 | Upgrade
|
| Last Close Price | 71.86 | 82.04 | 89.23 | 64.76 | 103.32 | 51.01 | Upgrade
|
| PE Ratio | 14.91 | 18.22 | 19.37 | 40.83 | 28.49 | 16.80 | Upgrade
|
| PS Ratio | 0.37 | 0.43 | 0.42 | 0.35 | 0.57 | 0.32 | Upgrade
|
| PB Ratio | 1.46 | 1.70 | 1.99 | 1.65 | 2.73 | 1.49 | Upgrade
|
| P/TBV Ratio | 1.84 | 1.81 | 2.14 | 1.79 | 2.93 | 1.60 | Upgrade
|
| P/FCF Ratio | - | 86.00 | 12.11 | - | 8.72 | 4.20 | Upgrade
|
| P/OCF Ratio | - | 6.47 | 6.28 | - | 5.97 | 3.57 | Upgrade
|
| EV/Sales Ratio | 0.84 | 0.87 | 0.81 | 0.67 | 0.92 | 0.73 | Upgrade
|
| EV/EBITDA Ratio | 10.23 | 10.23 | 9.75 | 8.54 | 11.77 | 7.49 | Upgrade
|
| EV/EBIT Ratio | 13.69 | 13.17 | 12.75 | 11.66 | 17.33 | 10.81 | Upgrade
|
| EV/FCF Ratio | - | 172.55 | 23.32 | - | 14.12 | 9.65 | Upgrade
|
| Debt / Equity Ratio | 1.98 | 1.97 | 1.98 | 2.09 | 1.82 | 2.12 | Upgrade
|
| Debt / EBITDA Ratio | 6.09 | 5.61 | 4.84 | 5.40 | 4.68 | 4.48 | Upgrade
|
| Debt / FCF Ratio | - | 99.67 | 12.03 | - | 5.82 | 5.97 | Upgrade
|
| Net Debt / Equity Ratio | 1.86 | 1.83 | 1.70 | 1.97 | 1.72 | 2.05 | Upgrade
|
| Net Debt / EBITDA Ratio | 6.05 | 5.51 | 4.32 | 5.28 | 4.59 | 4.47 | Upgrade
|
| Net Debt / FCF Ratio | - | 92.85 | 10.34 | -7.76 | 5.50 | 5.76 | Upgrade
|
| Asset Turnover | - | 0.93 | 1.07 | 1.06 | 1.12 | 1.05 | Upgrade
|
| Inventory Turnover | - | 1.71 | 2.13 | 2.07 | 2.56 | 2.41 | Upgrade
|
| Quick Ratio | - | 0.48 | 0.61 | 0.50 | 0.52 | 0.50 | Upgrade
|
| Current Ratio | - | 1.07 | 1.15 | 1.09 | 1.11 | 1.08 | Upgrade
|
| Return on Equity (ROE) | - | 9.69% | 10.98% | 4.29% | 10.20% | 9.55% | Upgrade
|
| Return on Assets (ROA) | - | 3.82% | 4.27% | 3.80% | 3.73% | 4.42% | Upgrade
|
| Return on Invested Capital (ROIC) | 8.48% | 9.68% | 9.28% | 5.51% | 5.76% | 10.38% | Upgrade
|
| Return on Capital Employed (ROCE) | - | 17.20% | 18.50% | 16.80% | 15.70% | 19.30% | Upgrade
|
| Earnings Yield | 7.10% | 5.49% | 5.16% | 2.45% | 3.51% | 5.95% | Upgrade
|
| FCF Yield | - | 1.16% | 8.26% | -15.41% | 11.46% | 23.81% | Upgrade
|
| Dividend Yield | 1.72% | 1.46% | 1.34% | 1.54% | 0.97% | 1.96% | Upgrade
|
| Payout Ratio | - | 26.48% | 21.22% | 60.55% | 26.41% | - | Upgrade
|
| Buyback Yield / Dilution | -14.04% | -0.74% | -0.30% | -5.86% | -4.39% | -0.19% | Upgrade
|
| Total Shareholder Return | -12.39% | 0.73% | 1.04% | -4.31% | -3.42% | 1.77% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.